)
Investor Relations14 Oct 2025
Boost Your Earnings Season Strategy With Real‑Time Alerts
Quartr Pro provides real time alerts, trend analysis and live coverage, giving analysts and investors instant insights to act faster in earnings.
Rallybio Corporation (RLYB) investor relations material
Rallybio Corporation Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2025 earnings summary7 Aug, 2025
Executive summary
Lead program RLYB116 advanced to a confirmatory PK/PD study, with topline data from Cohorts 1 and 2 expected in Q3 and Q4 2025.
RLYB212 program for FNAIT discontinued in April 2025 after Phase 2 trial failed to achieve target concentrations.
Interest in REV102 sold to Recursion in July 2025 for $7.5M upfront, with potential for $12.5M contingent equity and $5M milestone cash payment, plus royalties.
Workforce reduced by 40% in May 2025 to focus resources on lead and preclinical programs, incurring $1.7M in restructuring charges.
Cash, cash equivalents, and marketable securities totaled $45.7M as of June 30, 2025, expected to fund operations into mid-2027.
Financial highlights
Net loss was $9.7M for Q2 2025 ($0.22 per share), compared to $16.2M ($0.37 per share) in Q2 2024.
Revenue from collaboration and license agreements was $0.2M for Q2 2025 and $0.4M for the six months ended June 30, 2025.
Research and development expenses decreased to $6.1M in Q2 2025 from $12.9M in Q2 2024, mainly due to program discontinuation and workforce reduction.
General and administrative expenses were $4.2M in Q2 2025, down from $4.4M in Q2 2024.
Cash used in operating activities was $18.6M for the six months ended June 30, 2025, down from $25.9M year-over-year.
Outlook and guidance
Cash and marketable securities expected to fund operations into mid-2027, but not sufficient to fund product candidates through regulatory approval; additional capital will be needed.
RLYB116 confirmatory PK/PD study data anticipated in Q3 and Q4 2025; focus remains on advancing RLYB116 and preclinical programs.
Potential future milestone and royalty payments from the sale of REV102 interest to Recursion.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Rallybio Corporation earnings date
Q3 20256 Nov, 2025
Next Rallybio Corporation earnings date
Q3 20256 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Edge3 Oct 2025
Epiroc: A Culture of Moving Mountains
From automation to electrification, Swedish industrial giant Epiroc is leading a transformation in how the world mines.
)
Company Research22 Sep 2025
Moody's: Shaping Global Credit
Explore Moody's evolution from publishing manuals to becoming a giant in credit ratings, guiding issuers, investors, and regulators worldwide.
Frequently asked questions
Rallybio Corporation is a biotechnology company focused on developing therapies for rare and severe diseases. The company specializes in antibody and protein-based treatments targeting immune and hematological disorders. Its research and development efforts aim to address conditions with high unmet medical needs through clinical trials and collaborations with scientific partners. The company is headquartered in New Haven, Connecticut, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage